The Premier healthcare alliance is accepting applications for the third wave of its QUEST® Comparative Effectiveness & Innovation Program . Suppliers volunteer to partic
Industry Standard Research today announced the release of a new report focused on the impact comparative effectiveness research has and will have on formulary placement.
The draft, which offered insight into the Patient-Centered Outcomes Research Institute's priorities and research agenda, did not single out any specific diseases or treatments. The Institute did seek public comment.
In late 2011, a doctor named Joe Selby was charged with a very big task: Figure out which health care treatments are most effective. Selby is the first executive director of the Patient-Centered Outcomes Research Institute , an independent body created by the health reform law that has a $3 billion budget for comparative effectiveness research. Last week, PCORI published its inaugural agenda ...
The Patient-Centered Outcomes Research Institute, an independent board established by the health law, will meet this week to set priorities for "comparative effectiveness research." In other news related to the health law, the News Hour reports on how the overahul has impacted pediatric cancer patients and the New York Times reports on the law's provisions related to screening kids for obesity ...
Respected Academic Organizations to Examine Heterogeneity, CER & Payer Issues WASHINGTON, Jan. 30, 2012 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that it has selected five projects related to comparative effectiveness research (CER)...
This afternoon, in a hotel ballroom in Northern Florida, two dozen health policy wonks are quietly embarking on a momentous task: Determining what medical treatments are the most effective. The health reform law established the Patient-Centered Outcomes Research Institute (PCORI) as an independent advisory board with a $3 billion budget to support comparative effectiveness research. These are ...
WASHINGTON, Jan. 20, 2012 /PRNewswire-USNewswire/ -- National Pharmaceutical Council (NPC) Chief Science Officer Robert W. Dubois, M.D., Ph.D., today debuted a column, "From Methods to Policy," in the new peer-reviewed, bimonthly publication, Journal of Comparative Effectiveness Research. Dr. Dubois also serves as an associate editor for the Journal.